Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -123,564 | -72,829 | -31,586 | -211,505 | -180,996 |
| Depreciation Amortization | 36 | -441 | -528 | 464 | 1,078 |
| Income taxes - deferred | -176 | -209 | -50 | N/A | 0 |
| Accounts payable and accrued liabilities | -3,137 | 1,332 | -348 | 8,800 | 3,083 |
| Other Working Capital | -395 | -2,571 | -7,234 | 12,096 | 11,178 |
| Other Operating Activity | 40,153 | 19,570 | 9,490 | 145,492 | 142,485 |
| Operating Cash Flow | $-87,083 | $-55,148 | $-30,256 | $-44,653 | $-23,172 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36,679 | -18,279 | -10,423 | -5,332 | -4,011 |
| Purchase Of Investment | -162,931 | -101,756 | -52,397 | -649,307 | -315,399 |
| Sale Of Investment | 355,765 | 197,415 | 95,708 | 21,841 | N/A |
| Investing Cash Flow | $156,155 | $77,380 | $32,888 | $-632,798 | $-319,410 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 116,842 | 116,842 |
| Common Stock Issued | 2,486 | 920 | 684 | 355,059 | 11,375 |
| Other Financing Activity | 0 | 0 | 0 | 299,281 | 298,443 |
| Financing Cash Flow | $2,486 | $920 | $684 | $771,182 | $426,660 |
| Beginning Cash Position | 93,731 | 93,731 | 93,731 | N/A | N/A |
| End Cash Position | 165,289 | 116,883 | 97,047 | 93,731 | 84,078 |
| Net Cash Flow | $71,558 | $23,152 | $3,316 | $93,731 | $84,078 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,083 | -55,148 | -30,256 | -44,653 | -23,172 |
| Capital Expenditure | -36,679 | -18,279 | -10,423 | -5,332 | -4,011 |
| Free Cash Flow | -123,762 | -73,427 | -40,679 | -49,985 | -27,183 |